awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38207143-14B741F4-A83B-4F6C-9116-38BFE6BAEC19
Q38207143-14B741F4-A83B-4F6C-9116-38BFE6BAEC19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38207143-14B741F4-A83B-4F6C-9116-38BFE6BAEC19
Emerging therapies for refractory chronic lymphocytic leukemia.
P2860
Q38207143-14B741F4-A83B-4F6C-9116-38BFE6BAEC19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38207143-14B741F4-A83B-4F6C-9116-38BFE6BAEC19
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
19de26c6cab491c055269c8c2d756288d26aafcc
P2860
Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia.